EFSA published its conclusion on the peer review of garlic extract.
Updated EFSA conclusion on beta-cyfluthrin
EFSA published on 01.04.2020 a new version of its conclusions on the peer review of beta-cyfluthrin.
EFSA conclusion Kieselgur
EFSA published its conclusion on the peer review of kieselgur (diatomaceous earth), on 19.03.2020.
EFSA conclusions on peer review lavandulyl senecioate
After adopting a conclusion on the peer review of lavandulyl senecioate in December 2018, EFSA finally published the corresponding report.
EFSA conclusion chloropicrin
On 05.03.2020 EFSA published its conclusions on the peer review of chloropicrin.
EFSA conclusion blood meal
EFSA published the conclusions on the peer review of blood meal.
Benalaxyl peer review conclusions EFSA published
EFSA published its conclusions on the peer review of the (2nd) RAR for benalaxyl.
EFSA conclusion ferric pyrophosphate
EFSA published on 24.01.2020 the conclusion on the peer review of ferric pyrophosphate.
Clayed charcoal, EFSA report
EFSA published on 19.12.2019 a technical report on the possible expansion of the use of clayed charcoal.
Allium cepa extract, EFSA report
EFSA published a technical report on the outcome of the consultation on Allium cepa extract as a basic substance.
EFSA reports on Comfrey steeping
EFSA published on11.12.2019 a Technical Report on the outcome of the consultation with Member States on the basic substance application for Comfrey steeping.
EFSA conclusion peer review DMDS
On 25.11.2019 EFSA published its conclusions on the peer review of dimethyl disulfide.
Benfluralin EFSA conclusion published
On 15.11.2019 EFSA published its conclusions on the peer review of benfluralin.
EFSA conclusion pydiflumetofen
On 11.10.2019 EFSA published its conclusions on the peer review of pydiflumetofen.
Indoxacarb updated EFSA conclusions
EFSA published on 27.09.2019 an update on its conclusions on the peer review of indoxacarb.
Ziram renewal further delayed by Endrocrine Disruption assessment
On 24.9.2019 the EFSA Register of Questions was updated with regard to an additional data request for ziram on endocrine disrupting effects.
Pyriproxyfen EFSA conclusions published
On 17.07.2019 EFSA published its conclusions on the peer review of pyriproxyfen.
EFSA Conclusion on sulfoxaflor confirmatory data
On 28.03.2019 EFSA published its conclusions on the peer review of confirmatory data for sulfoxaflor.
EFSA conclusions peer review & Art. 4.7 of thiacloprid published
on 14.03.2019 EFSA published its conclusions on the peer review of thiacloprid.
Legal action Amvac vs. EFSA
On 18 February a new case (T-720/18) from AMVAC against EFSA was published in the Official Journal.